edward life skanss, e.w., one of your choice here. heart disease treatment is its area in science. why edwards? >> well, it is unique. in that it does offer products and services for the late-stage cardiovascular disease. but here, again, its subcategory in health care looks very good and the overall health care sector looks very good. it's not something receipt because of migration into defensive growth while the market corrects. this has been ongoing for many years. we like the health care group. i think it's gained an extra kick because of the focus looking for other opportunities other than the cyclicals, materials, metals, and under investigation. so this should give the health care group a bit more boost. many of the subcongratulations of health care continue to show very prom naptly on our charts, on our money flow characteristics. >> tom: let's tack a look at the previous picks you had on november 12. you liked these four stocks. c.f., up 4%. eaton whiting petroleum up 17.5. three for four. do you still like this quartet? >> i do. i like it as far as the individual holdings